Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts. It is the third oldest general hospital in the United States and has a capacity of 999 beds.

There are 999 beds in Massachusetts General Hospital.

During the past decade, Massachusetts General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital" #1 collaborator was "Emory University" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "Seattle Children's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital" are "Adrenal Insufficiency" (1 trials), "Arrythmia" (1 trials), "Asthma in Children" (1 trials), "Attention Deficit Hyperactivity Disorder" (1 trials) and "Autism Spectrum Disorder" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Inebilizumab" (1 trials), "Placebo" (1 trials), "RG7314" (1 trials), "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:" (1 trials) and "extended-release guanfacine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Massachusetts General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".